# Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-and-biomarker-study-of-pembrolizumab-plus-bevacizumab-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lakshmi Nayak,Annette M. Molinaro,Katherine B. Peters,Jennifer Clarke,Justin T. Jordan,John de Groot,Leia Nghiemphu,Thomas Kaley,Howard Colman,Christine McCluskey,Sarah Gaffey,Timothy R. Smith,David J. Coté,Mariano Severgnini,Jennifer H. Yearley,Qing Zhao,Wendy M. Blumenschein,Dan G. Duda,Alona Muzikansky,Rakesh K. Jain,Patrick Y. Wen,David A. Reardon |
| Citations | 263 |
| DOI | 10.1158/1078-0432.ccr-20-2500 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/27/4/1048/2068105/1048.pdf |
| OpenAlex ID | https://openalex.org/W3099035428 |
| PMID | 33199490 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Alona Muzikansky](https://scholariq.org/researchers/alona-muzikansky/)
- [Howard Colman](https://scholariq.org/researchers/howard-colman/)
- [Katherine B. Peters](https://scholariq.org/researchers/katherine-b-peters/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.